Evidence map›Paper›PMID 22311661›Full record

ArticleBirth defects research. Part B, Developmental and reproductive toxicology2012

Cannabinoid receptor 1 signaling in embryo neurodevelopment.

Delphine Psychoyos, K Yaragudri Vinod, Jin Cao, Shan Xie, Richard L Hyson, Bogdan Wlodarczyk, Weimin He, Thomas B Cooper, Basalingappa L Hungund, Richard H Finnell

Abstract read
In one paragraph

Article in Birth defects research. Part B, Developmental and reproductive toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cannabinoid exposure during pregnancy and its impact on immune function.Cellular and molecular life sciences : CMLS · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Legal highs: staying on top of the flood of novel psychoactive substances.Therapeutic advances in psychopharmacology · 2015
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Delphine PsychoyosCenter for Environmental and Genetic Medicine, Texas A&M Health Science Center, Houston, Texas 77030, USA. dpsychoyos@ibt.tamhsc.edu
K Yaragudri Vinod
Jin Cao
Shan Xie
Richard L Hyson
Bogdan Wlodarczyk
Weimin He
Thomas B Cooper
Basalingappa L Hungund
Richard H Finnell
Texas A&M Health Science Center · USColumbia University · USThe University of Texas at Austin · USFlorida State University · USNathan Kline Institute for Psychiatric Research · USNew York University · US

Funding

ENDOCANNABINOIDS AND VOLUNTARY ETHANOL CONSUMPTIONR21AA015525 · NIAAA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI HUNGUND, BASALINGAPPA LINGAPPA · 2005 to 2008
$409k
Role of the Endocannabinoid Signaling in Fetal Alcohol Spectrum DisordersR21AA018709 · NIAAA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI YARAGUDRI, VINOD K · 2011 to 2012
$400k
Prenatal Cannabis Effect on the Endocannabinoid SystemR21DA020531 · NIDA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI YARAGUDRI, VINOD K · 2007 to 2008
$372k
Proteomic analyses following deafnessR21DC011121 · NIDCD · FLORIDA STATE UNIVERSITY · PI HYSON, RICHARD L. · 2010 to 2011
$341k
Teratogenic Effects of Marijuana in Developing Chick CNSF32DA021977 · NIDA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI PSYCHOYOS, DELPHINE · 2008 to 2010
$178k
NIAAA NIH HHS AA015525NIAAA NIH HHS AA018709NIAAA NIH HHS R21 AA015525NIAAA NIH HHS R21 AA018709NIDA NIH HHS 1F32 DA021977NIDA NIH HHS DA020531NIDA NIH HHS F32 DA021977NIDA NIH HHS R21 DA020531NIDCD NIH HHS DC011121NIDCD NIH HHS R21 DC011121
6 · The paper itself

Abstract

In utero exposure to tetrahydrocannabinol, the psychoactive component of marijuana, is associated with an increased risk for neurodevelopmental defects in the offspring by interfering with the functioning of the endocannabinoid (eCB) system. At the present time, it is not clearly known whether the eCB system is present before neurogenesis. Using an array of biochemical techniques, we analyzed the levels of CB1 receptors, eCBs (AEA and 2-AG), and the enzymes (NAPE-PLD, DAGLα, DAGLβ, MAGL, and FAAH) involved in the metabolism of the eCBs in chick and mouse models during development. The findings demonstrate the presence of eCB system in early embryo before neurogenesis. The eCB system might play a critical role in early embryogenesis and there might be adverse developmental consequences of in utero exposure to marijuana and other drugs of abuse during this period.

Indexed as

AnimalsArachidonic AcidsCannabinoid Receptor ModulatorsChick EmbryoChromatography, LiquidDronabinolEmbryo, MammalianEndocannabinoidsEndpoint DeterminationFemaleGlyceridesMass SpectrometryMiceNeurogenesisPolyunsaturated AlkamidesProsencephalonanandamideArachidonic AcidsCannabinoid Receptor ModulatorsDronabinolEndocannabinoidsGlyceridesglyceryl 2-arachidonatePolyunsaturated AlkamidesReceptor, Cannabinoid, CB1

Identifiers

PMID22311661
PMCPMC4175447
OpenAlexW1542322300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.